Low-level laser therapy in the treatment of mucous membrane pemphigoid: a promising procedure.
BACKGROUND
Mucous membrane pemphigoid is a heterogeneous group of autoimmune, subepithelial, blistering diseases. A combination of topical and systemic steroid treatment is often used when managing patients with mucous membrane pemphigoid. The use of systemic steroids presents an increased risk of adverse side effects. Consequently, effective alternative modalities of therapy should be considered, such as the application of low-level laser therapy (LLLT).


METHODS
A patient presented with mucous membrane pemphigoid and was successfully treated with the application of local corticosteroids and LLLT using an 810-nm diode laser. The lesions were treated by LLLT over a period of 7 days using a continuous waveform for 40 seconds and an energy density of 5 J/cm(2).


RESULTS
After treatment, a significant improvement in tissue color and consistency was observed. The patient was followed every month for a period of 12 months, and the lesions healed uneventfully.


CONCLUSIONS
The results reported in this case show that the healing of mucous membrane pemphigoid was achieved when LLLT was used as an adjunct to the application of a local corticosteroid.
Yilmaz
Hasan Guney
HG
Department of Periodontology, Faculty of Dentistry, Near East University, Mersin, Turkey. dr.hguneyyilmaz@gmail.com
Kusakci-Seker
Basak
B
Bayindir
Hakan
H
Tözüm
Tolga Fikret
TF
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001624:Betamethasone Valerate / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005882:Gingival Diseases / Q000188:drug therapy / Q000532:radiotherapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D054023:Lasers, Semiconductor / Q000627:therapeutic use*; D028022:Low-Level Light Therapy; D008875:Middle Aged; D009824:Ointments; D010390:Pemphigoid, Benign Mucous Membrane / Q000188:drug therapy / Q000532:radiotherapy*; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; D001624:Betamethasone Valerate; D014222:Triamcinolone Acetonide